Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Keye (YC F24)
start up
United States
- New York, NY
- 30/07/2025
- Seed
- $5,000,000
Keye is an AI-enabled platform that empowers PE funds to perform their due diligence significantly faster and more accurately. Built by experts from Goldman Sachs, Vista Equity Partners, and Tesla, Keye is designed for the speed and depth that today’s private market investors demand. By eliminating tedious data aggregation and manual analysis, we enable investment teams to really focus on getting a deeper understanding of the business's underlying levers. With Keye, investors save time, make better investments, do more deals, and see superior returns.
- Industry Technology, Information and Internet
- Website https://www.keye.co/
- LinkedIn https://www.linkedin.com/company/keye/
KrisAtWork | $3,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)